Malignant Extrahepatic Bile Duct Neoplasm

Malignant Extrahepatic Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

162 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 3%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 51–67 of 67 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00356889	Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	completed	Phase 2	56	National Cancer Institute (NCI)NIH	1	May 28, 2014	clinicaltrials
NCT00023946	BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	terminated	Phase 2	50	National Cancer Institute (NCI)NIH	1	May 14, 2014	clinicaltrials